Revefenacin is a long-acting muscarinic antagonist (LAMA) bronchodilator used as a once-daily nebulized treatment for maintenance therapy in chronic obstructive pulmonary disease (COPD). It features a labile primary amide that enables rapid systemic clearance, potentially minimizing systemic side effects.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Revefenacin?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Eluxadoline
pharmaceutical raw material
Сiprofloxacin hydrochloride
pharmaceutical raw material
Fostemsavir tromethamine
pharmaceutical raw material
Islatravir
pharmaceutical raw material
The international HS code for Revefenacin (CAS 864750-70-9) is 2933.39.
2933.39
2933 39 99
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
[1-[2-[[4-[(4-carbamoylpiperidin-1-yl)methyl]benzoyl]-methylamino]ethyl]piperidin-4-yl] N-(2-phenylphenyl)carbamate
FYDWDCIFZSGNBU-UHFFFAOYSA-N
CN(CCN1CCC(CC1)OC(=O)NC2=CC=CC=C2C3=CC=CC=C3)C(=O)C4=CC=C(C=C4)CN5CCC(CC5)C(=O)N
Sourcing Revefenacin?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.